Article
Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Antimicrobial agents and chemotherapy - 1 Feb 2005
Iliades Peter, Meshnick Steven R, Macreadie Ian G
Abstract excerpt
Pneumocystis jirovecii is a major opportunistic pathogen that causes Pneumocystis pneumonia (PCP) and results in a high degree of mortality in immunocompromised individuals. The drug of choice for PCP is typically sulfamethoxazole (SMX) or dapsone in conjunction with trimethoprim. Drug treatment failure and sulfa drug resistance have been implicated epidemiologically with point mutations in dihydropteroate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
